You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

STI 571

Showing 1 - 25 of 477
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignant Solid Tumor, C-KIT Tyrosine Kinase Protein Overexpression, Clinical Stage IV Cutaneous Melanoma AJCC v8 Trial

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +8 more
  • Imatinib Mesylate
  • Ipilimumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 1, 2022

Gastrointestinal Stromal Tumor (GIST) Trial in New York (drug, other, procedure)

Active, not recruiting
  • Gastrointestinal Stromal Tumor (GIST)
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Dec 28, 2022

Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma Trial in Seattle (drug, other, biological)

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • Lymphoblastic Lymphoma
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jun 18, 2022

Systemic Sclerosis, Scleroderma Trial in Worldwide (STI571)

Completed
Has Results
  • Systemic Sclerosis, Scleroderma
  • Chicago, Illinois
  • +6 more
Jul 5, 2021

Liver Fibrosis Trial in Tehran (Imatinib 200mg, Placebo)

Active, not recruiting
  • Liver Fibrosis
  • Imatinib 200mg
  • Placebo
  • Tehran, Iran, Islamic Republic of
    Research Institute of Gastroenterology & Liver Diseases
Jan 24, 2022

Philadelphia Positive Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (STI571

Completed
Has Results
  • Philadelphia Positive Chronic Myeloid Leukemia
  • +2 more
  • STI571 400 mg
  • STI571 600 mg
  • Boston, Massachusetts
  • +11 more
Jul 1, 2021

Chronic Myelomonocytic Leukemia, Chronic Myeloid Leukemia, Polycythemia Vera Trial in Houston (Imatinib Mesylate (Gleevec))

Completed
Has Results
  • Chronic Myelomonocytic Leukemia
  • +4 more
  • Imatinib Mesylate (Gleevec)
  • Houston, Texas
    UT MD Anderson Cancer Center
Dec 7, 2021

Gastrointestinal Stromal Tumor Trial in Philadelphia (Conventional Surgery, Imatinib Mesylate)

Completed
Has Results
  • Gastrointestinal Stromal Tumor
  • Conventional Surgery
  • Imatinib Mesylate
  • Philadelphia, Pennsylvania
    Radiation Therapy Oncology Group
Oct 22, 2020

Leukemia, Myelogenous, Chronic, BCR-ABL Positive Trial in Worldwide (STI571)

Completed
Has Results
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Los Angeles, California
  • +27 more
Jul 1, 2021

Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Minimal Residual

Terminated
  • Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 1, 2020

Gastrointestinal Stromal Tumors Trial in Worldwide (RAD001, Imatinib 600mg/day (Glevec is the brand name for imatinib), Imatinib

Completed
Has Results
  • Gastrointestinal Stromal Tumors
  • Boston, Massachusetts
  • +15 more
Jun 3, 2021

Uterine Cancer Trial in Houston (Imatinib Mesylate, Paclitaxel)

Terminated
Has Results
  • Uterine Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 26, 2020

Philadelphia Chromosome Positive CML Trial in Worldwide (imatinib mesylate)

Completed
Has Results
  • Philadelphia Chromosome Positive CML
  • imatinib mesylate
  • Chicago, Illinois
  • +9 more
Jun 3, 2021

Gastrointestinal Stromal Tumors Trial in Worldwide (AMN107, STI571)

Completed
  • Gastrointestinal Stromal Tumors
  • AMN107, STI571
  • Boston, Massachusetts
  • +4 more
Dec 6, 2020

GIST and CML Trial in Worldwide (imatinib mesylate)

Active, not recruiting
  • GIST and CML
  • imatinib mesylate
  • Los Angeles, California
  • +28 more
Apr 25, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Estrogen Receptor Positive, KIT Positive Trial in Houston (Imatinib Mesylate,

Completed
Has Results
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 14, 2020

Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in Uijeongbu si (Asciminib single agent, Asciminib, Imatinib)

Recruiting
  • Chronic Myelogenous Leukemia
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive
  • Asciminib single agent
  • +5 more
  • Ann Arbor, Michigan
  • +49 more
Jan 26, 2023

CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

Recruiting
  • CML
  • +3 more
  • Asciminib add-on
  • +3 more
  • Augusta, Georgia
  • +46 more
Jan 23, 2023

Melanoma, Advanced Melanoma Trial in Philadelphia (Gleevec + Temozolomide)

Terminated
  • Melanoma
  • Advanced Melanoma
  • Gleevec + Temozolomide
  • Philadelphia, Pennsylvania
    Abramson Cancer Center at University of Pennsylvania
Apr 6, 2020

3rd Line GIST Trial in Worldwide (STI571, BKM120)

Completed
  • 3rd Line GIST
  • Boston, Massachusetts
  • +10 more
Dec 17, 2020

Sclerotic GVHD, Imatinib Mesylate Trial run by the NCI (Gleevec, STI571(Imatinib Mesylate))

Completed
Has Results
  • Sclerotic Graft Versus Host Disease
  • Imatinib Mesylate
  • Gleevec, STI571(Imatinib Mesylate)
  • Bethesda, Maryland
    National Cancer Institute (NCI), 9000 Rockville Pike
Mar 27, 2020

Chronic Myeloid Leukemia Trial in Poitiers (Imatinib mesylate 400 mg, Imatinib mesylate 600 mg, Imatinib 400 mg +

Completed
  • Chronic Myeloid Leukemia
  • Imatinib mesylate 400 mg
  • +3 more
  • Poitiers, France
    University Hospital
Apr 10, 2020

Adult Acute Lymphoblastic Leukemia in Remission, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1,

Completed
Has Results
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +9 more
  • Denver, Colorado
  • +2 more
Jan 17, 2020

Chronic Myelogenous Leukemia Trial in Canada, United States (decitabine (5-aza-2'deoxycytidine))

Completed
  • Chronic Myelogenous Leukemia
  • decitabine (5-aza-2'deoxycytidine)
  • Duarte, California
  • +7 more
Jan 13, 2020

Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Minimal Residual Disease Trial in United States (drug, other,

Recruiting
  • Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
  • Minimal Residual Disease
  • Goodyear, Arizona
  • +237 more
Jan 3, 2023